Antithrombin III deficiency: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
{{CMG}}; {{AE}}{{MKA}}, {{S.G.}} | {{CMG}}; {{AE}}{{MKA}}, {{S.G.}} | ||
{{SK}} Antithrombin 3 deficiency | {{SK}} Antithrombin 3 deficiency, Congenital AT-III Deficiancy, | ||
==[[Antithrombin III deficiency overview|Overview]]== | ==[[Antithrombin III deficiency overview|Overview]]== | ||
Latest revision as of 22:48, 14 July 2020
| Antithrombin III deficiency | |
| ICD-9 | 289.81 |
|---|---|
| OMIM | 107300 |
| DiseasesDB | 783 |
| MeSH | D020152 |
For patient information click here
|
Antithrombin III deficiency Microchapters |
|
Differentiating Antithrombin III deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Antithrombin III deficiency On the Web |
|
American Roentgen Ray Society Images of Antithrombin III deficiency |
|
Directions to Hospitals Treating Antithrombin III deficiency |
|
Risk calculators and risk factors for Antithrombin III deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2], Sogand Goudarzi, MD [3]
Synonyms and keywords: Antithrombin 3 deficiency, Congenital AT-III Deficiancy,
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Antithrombin III deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies